Generative AI is an important growth driver for Alphabet's Google Cloud unit. Alphabet is integrating ... Those generative AI products include Vertex AI Studio, which helps customers rapidly ...

Those generative AI products include Vertex AI Studio ... While Google Cloud (like AWS and Microsoft) uses Nvidia's GPUs, the unit also relies upon its own chips to handle generative AI models.

Vertex and Novartis achieved revenue increases ... The performance is evidence that the company has come full circle from the loss of exclusivity of megablockbuster Humira and that its next ...

Investors with a lot of money to spend have taken a bearish stance on Vertex Pharmaceuticals VRTX. And retail traders should know. We noticed this today when the trades showed up on publicly ...

Vertex Pharmaceuticals (Nasdaq: VRTX) specialises in treatments for rare diseases. It has eight approved medicines on the market. Seven of these are medicines for various types of cystic fibrosis ...

Vertex (NASDAQ:VERX – Free Report) had its price target reduced by Robert W. Baird from $62.00 to $45.00 in a research report report published on Friday morning,Benzinga reports. Robert W.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has recently achieved a significant milestone with the FDA's approval of JOURNAVX(suzetrigine), a novel non-opioid pain medication. This approval marks ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Growth-stage investment firm A91 Partners, which is currently raising a new venture capital fund that could increase its total assets under management to over $1.5 billion (Rs 12,900 crore), is in ...